BASIC FIBROBLASTIC GROWTH FACTOR WITH A SPECIFIC COLLAGEN BINDING DOMAIN

摘要

The invention relates to a basic fibroblastic growth factor (bFGF) with a specific collagen binding domain that is obtained by recombinant DNA technology, which includes a 10 amino acid fragment corresponding to the modified collagen binding factor of the von Willebrand factor (vWF). The new controlled release factor is used as a therapeutic agent in the cicatrization of wounds and in other tissue repair processes.